Chloroquine and Hydroxychloroquine for COVID-19: A Word of Caution
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Approaches towards fighting the COVID‑19 pandemic (Review).
Tsai S, Lu C, Bau D, Chiu Y, Yen Y, Hsu Y Int J Mol Med. 2020; 47(1):3-22.
PMID: 33236131 PMC: 7723515. DOI: 10.3892/ijmm.2020.4794.
Chloroquine and hydroxychloroquine for COVID-19: A word of caution.
Annangi S Respirology. 2020; 25(7):683-684.
PMID: 32394513 PMC: 7272900. DOI: 10.1111/resp.13845.
References
1.
Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P
. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020; 71(15):732-739.
PMC: 7108130.
DOI: 10.1093/cid/ciaa237.
View
2.
Annangi S
. Chloroquine and hydroxychloroquine for COVID-19: A word of caution. Respirology. 2020; 25(7):683-684.
PMC: 7272900.
DOI: 10.1111/resp.13845.
View
3.
Shah S, Das S, Jain A, Misra D, Negi V
. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). Int J Rheum Dis. 2020; 23(5):613-619.
PMC: 7262257.
DOI: 10.1111/1756-185X.13842.
View
4.
Chorin E, Dai M, Shulman E, Wadhwani L, Bar-Cohen R, Barbhaiya C
. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Nat Med. 2020; 26(6):808-809.
DOI: 10.1038/s41591-020-0888-2.
View
5.
Gautret P, Lagier J, Parola P, Hoang V, Meddeb L, Mailhe M
. RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949.
PMC: 7102549.
DOI: 10.1016/j.ijantimicag.2020.105949.
View